Dallas Drugs Private Limited

Produces pharmaceuticals under previous name Friska Foods Private Limited.

2012 | Chandigarh (India) | Active
Last Updated:

Dallas Drugs Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 2.50 Cr
  • Company Age 13 Year, 20 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.28 Cr
  • Revenue Growth -18.72%
  • Profit Growth 105.72%
  • Ebitda 626.51%
  • Net Worth 17.34%
  • Total Assets -11.10%

About Dallas Drugs

Dallas Drugs Private Limited (DDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 April 2012 and has a history of 13 years. Its registered office is in Chandigarh, India.

The Corporate was formerly known as Friska Foods Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.50 Cr.

The company currently has active open charges totaling ₹11.28 Cr.

Rajesh Gupta and Anil Kumar serve as directors at the Company.

Company Details

  • Location

    Chandigarh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U15400CH2012PTC033748

  • Company No.

    033748

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    25 Apr 2012

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chandigarh

Industry

Pharma
Company report

Dallas Drugs Private Limited

Explore comprehensive data for Dallas Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Dallas Drugs?

Board Members (2)

NameDesignationAppointment DateStatus
Anil Kumar Country flag representing In Director 29-Sep-2018Current
Rajesh Gupta Country flag representing In Director 29-Sep-2018Current

Financial Performance of Dallas Drugs.

Dallas Drugs Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 18.72% decrease. The company also saw a substantial improvement in profitability, with a 105.72% increase in profit. The company's net worth Soared by an impressive increase of 17.34%.

Dallas Drugs revenue growth over time
Dallas Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-18.72%
Revenue from Operations
-18.68%
Total Assets
-11.10%
Profit or Loss
105.72%
Net Worth
17.34%
EBITDA
626.51%

What is the Ownership and Shareholding Structure of Dallas Drugs?

Unlock access to Dallas Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹11.28 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of India : 11.28 Cr

Latest Charge Details

DateLenderAmountStatus
20 Apr 2019State Bank Of India₹11.28 CrOpen

How Many Employees Work at Dallas Drugs?

Dallas Drugs has a workforce of 23 employees as of Dec 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Dallas Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dallas Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dallas Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dallas Drugs

Recent activity within the organization

  • Annual General Meeting

    Dallas Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Dallas Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.

  • Charges

    A charge with State Bank Of India of Rs. 11.28 Cr registered on 20 Apr 2019 with Charge ID 100268414 was modified on 10 May 2023.

  • Charges

    A charge with State Bank Of India amounted to Rs. 11.28 Cr with Charge ID 100268414 was registered on 20 Apr 2019.

  • Director Appointment

    Rajesh Gupta was appointed as a Director was appointed as a Director on 29 Sep 2018 & has been associated with this company since 6 years 7 months .

  • Director Appointment

    Anil Kumar was appointed as a Director was appointed as a Director on 29 Sep 2018 & has been associated with this company since 6 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Dallas Drugs Private Limited?

    Dallas Drugs Private Limited was incorporated on 25 Apr 2012.

  • What is authorized share capital and paid-up capital of Dallas Drugs Private Limited?

    The authorized share capital of Dallas Drugs Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 2.50 Cr.

  • Who are the current board members & directors of Dallas Drugs Private Limited?

    Currently 2 directors are associated with Dallas Drugs Private Limited.

    • Rajesh Gupta
    • Anil Kumar

  • What is the registered address of Dallas Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Dallas Drugs Private Limited is Sco No. 805 1St Floor (Half Portion At Floor) N.A.C Manimajra, India, Chandigarh, 160002.

  • What is the corporate identification number (CIN) and company number of Dallas Drugs Private Limited?

    The corporate identification number (CIN) of Dallas Drugs Private Limited is U15400CH2012PTC033748 and the company number is 033748 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Dallas Drugs Private Limited?

    The Official website of Dallas Drugs Private Limited is https://www.dallasdrugs.org

  • What has been the recent revenue trend for Dallas Drugs Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Dallas Drugs Private Limited has fallen by -18.72%.

  • How many employees does Dallas Drugs Private Limited currently have?

    As Per 2024 financial reports, 23 employees are currently employed by Dallas Drugs Private Limited.

  • What change has been observed in the net worth of Dallas Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Dallas Drugs Private Limited has experienced an upsurge of 17.34%.

  • What are the total open charges for Dallas Drugs Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Dallas Drugs Private Limited amount to ₹ 11.28 Cr.

  • When was the last Balance Sheet of Dallas Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Dallas Drugs Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development